5 Stocks Pushing The Health Care Sector Higher

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 15 points (0.1%) at 12,980 as of Tuesday, Dec. 4, 2012, 11:49 AM ET. The NYSE advances/declines ratio sits at 1,319 issues advancing vs. 1,553 declining with 162 unchanged.

The Health Care sector currently sits down 0.3% versus the S&P 500, which is down 0.1%. Top gainers within the sector include Edwards Life ( EW), up 4.5%, Shire ( SHPG), up 2.7%, Valeant Pharmaceuticals International ( VRX), up 1.1%, Abbott Laboratories ( ABT), up 0.8% and GlaxoSmithKline ( GSK), up 0.8%.

TheStreet Ratings group would like to highlight 5 stocks pushing the sector higher today:

5. Teva Pharmaceutical Industries ( TEVA) is one of the companies pushing the Health Care sector higher today. As of noon trading, Teva Pharmaceutical Industries is up $0.70 (1.7%) to $41.25 on average volume Thus far, 2.0 million shares of Teva Pharmaceutical Industries exchanged hands as compared to its average daily volume of 3.1 million shares. The stock has ranged in price between $40.37-$41.32 after having opened the day at $40.37 as compared to the previous trading day's close of $40.55.

Teva Pharmaceutical Industries Limited develops, manufactures, and sells pharmaceutical products worldwide. Teva Pharmaceutical Industries has a market cap of $35.0 billion and is part of the drugs industry. The company has a P/E ratio of 10.9, below the S&P 500 P/E ratio of 17.7. Shares are down 0.0% year to date as of the close of trading on Monday. Currently there are 16 analysts that rate Teva Pharmaceutical Industries a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Teva Pharmaceutical Industries as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full Teva Pharmaceutical Industries Ratings Report now.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass

If you liked this article you might like

S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed

S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed

S&P 500 and Dow Aim for New Records With Broad-Based Gains Ahead of Fed

Dow and S&P 500 Reach New Intraday Highs With Markets in Good Mood Ahead of Fed

Teva's New CEO Brings This Secret Weapon